Adjuvant Therapy in High-Risk Prostate Cancer after Radical Prostatectomy - A Randomized, open-label, Phase 2 Study of Adjuvant Apalutamide or Standard of Care in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy (ADAM) - Study AP 116/21 of AUO

Saved in:
Bibliographic Details
Published inAktuelle Urologie Vol. 54; no. 1; p. 21
Format Journal Article
LanguageGerman
Published Germany 01.02.2023
Subjects
Combined Modality Therapy
Humans
Male
Prostatectomy
Prostatic Neoplasms - drug therapy
Prostatic Neoplasms - surgery
Standard of Care
Online AccessGet more information

Cover

More Information
ISSN:1438-8820
DOI:10.1055/a-1942-9689